The evolution of immunosuppressant therapy in renal transplantation.
Cole
Edward
E
University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada.
D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D016030:Kidney Transplantation; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use; D016019:Survival Analysis
D007166:Immunosuppressive Agents; D020123:Sirolimus